S&P 500
(0.10%) 5 253.66 points
Dow J
(0.06%) 39 785 points
Nasdaq
(0.00%) 16 399 points
Oil
(1.52%) $82.59
Gas
(0.58%) $1.728
Gold
(2.04%) $2 235.20
Silver
(0.71%) $24.93
Platinum
(1.35%) $922.00
USD/EUR
(0.28%) $0.926
USD/NOK
(0.68%) $10.84
USD/GBP
(0.04%) $0.792
USD/RUB
(0.17%) $92.59

Realtime updates for Neuren Pharmaceuticals [NEU.AX]

Exchange: ASX Industry: Pharmaceuticals, Biotechnology & Life Sciences
Last Updated28 Mar 2024 @ 01:10

2.17% $ 21.22

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 01:10):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Neuren Pharmaceuticals Limited, a biopharmaceutical company, develops drugs for the treatment of neurological disorders. Its lead product is trofinetide, which is in Phase III clinical trial for the treatment of Rett syndrome, as well as has completed Phase II clinical trial to treat Fragile X syndrome...

Stats
Today's Volume 373 711
Average Volume 532 276
Market Cap 2.70B
EPS $0 ( 2024-02-21 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 17.68
ATR14 $0.0280 (0.13%)

Volume Correlation

Long: 0.09 (neutral)
Short: -0.78 (moderate negative)
Signal:(32.342) Neutral

Neuren Pharmaceuticals Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Neuren Pharmaceuticals Correlation - Currency/Commodity

The country flag 0.63
( weak )
The country flag 0.62
( weak )
The country flag 0.00
( neutral )
The country flag 0.45
( neutral )
The country flag -0.29
( neutral )
The country flag -0.67
( moderate negative )

Neuren Pharmaceuticals Financials

Annual 2023
Revenue: $231.93M
Gross Profit: $231.93M (100.00 %)
EPS: $1.240
Q4 2023
Revenue: $169.00M
Gross Profit: $169.00M (100.00 %)
EPS: $0.860
Q2 2023
Revenue: $62.93M
Gross Profit: $51.84M (82.38 %)
EPS: $0.380
Q4 2022
Revenue: $14.55M
Gross Profit: $14.55M (99.96 %)
EPS: $0.0575

Financial Reports:

No articles found.

Neuren Pharmaceuticals

Neuren Pharmaceuticals Limited, a biopharmaceutical company, develops drugs for the treatment of neurological disorders. Its lead product is trofinetide, which is in Phase III clinical trial for the treatment of Rett syndrome, as well as has completed Phase II clinical trial to treat Fragile X syndrome. The company also develops NNZ-2591, which has completed Phase I clinical trial for the treatment of Phelan-McDermid, Angelman, Pitt Hopkins, and Prader-Will syndromes. In addition, it provides development services; and holds loan funded shares. The company was incorporated in 2001 and is based in Camberwell, Australia.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators